Mechanical support

Temporary ECMO resources
J. Barker (Manchester, UK)
Paediatric ECMO
R Firmin (Leicester, UK) presents an overview
ECMO for thoracic pathology
P-E Falcoz (Strasbourg, France) describes the different types of ECMO available for thoracic patients and considers future developments.
Thoracic surgery ECMO
P-E Falcoz (Strasburg, France) gives a detailed overview of the use of extracorporeal membrane oxygenation (ECMO) in thoracic surgery. He describes the different cannulation options and looks at future possibilities.
Postoperative mechanical circulatory support
Professor Stephen Westaby of John Radcliffe Hospital, Oxford, UK gives an overview of the use of temporary mechanical support for post cardiotomy failure.
Temporary MCS: US perspective
M. Acker (Philadelphia, US)
Transoesophageal echocardiography in Mechanical Assist
J Ender (Leipzig, Germany) discusses the use of transoesophageal echocardiography in the setting of mechanical circulatory support.
Biventricular mechanical support
M Struber (Leipzig, Germany) describes off-pump LVAD insertion before discussing biventricular support.
VAD patient management
A Zuckermann (Vienna, Austria) gives an overview of VAD patient management, with particular emphasis on potential complications.
VAD therapy as new gold standard
S Schueler (Newcastle, UK) reviews the history of heart transplantation before arguing that LVAD therapy is now the new gold standard.
Future of VAD therapy
J Treiber (Thoratec) presents a vision for the future of ventricular assist device therapy.
Heartware ventricular assist update
J Begg (Heartware) describes the Heartware HVAD and MVAD devices for mechanical circulatory support.
Bridging to heart transplantation
A Simon (London, UK) discusses the changing pattern of heart transplantation urgency and the likelihood of a patient on a device receiving a transplant.
Temporary mechanical support for critical cardiogenic shock
R. Venkateswaran (Manchester, UK) discusses temporary mechanical circulatory support as a bridge to transplantation in cardiogenic shock, considering the pathophysiology and the strategies which help decision-making.
UK destination therapy
S Schueler (Newcastle, UK) discusses destination therapy as an option for heart failure in the UK.
Berlin Heart developments
U Opfermann (Berlin, Germany) describes developments in Berlin Heart technology.